AUG 24, 2020 6:12 AM PDT

New Portable MRI Swoops Into Hospital Rooms, Gets FDA Nod

WRITTEN BY: Tara Fernandez

 

Magnetic resonance imaging, or MRI, is a medical imaging technique that uses powerful magnetic fields and radio waves to generate detailed, intricate 3-dimensional images of the organs and tissues inside the body. These machines are large and tubular and patients lie inside the machine where magnetic fields temporarily realign the water molecules inside them. The applied radio waves then cause these aligned water molecules to emit signals, which are then used by the machine to put together cross-sectional images, which can then be viewed by medical staff at any angle.

Though MRIs are an integral tool for making a clinical diagnosis for a wide array of conditions, not everyone is able to access it, as MRI machines are operated only in specialized facilities. Recently, the company Hyperfine has released FDA clearance for the first portable MRI machine that can be easily wheeled directly to where the patient is — a device called the Swoop™.

Compared to 13,000 lb standard MRI machines, the Swoop™ is relatively tiny, weighing in at around 1,400 lbs and plugging right into standard electrical wall outlets in hospital rooms. The device can be operated wirelessly via a tablet. Another benefit, says the creators, is the cost to healthcare providers, with the Swoop™ costing less than the annual service contract alone for current MRI systems and consumes 35 times less power. Such point-of-care technologies are revolutionizing the patient experience, allowing for a higher standard of care across all age ranges, physical conditions, and mobilities.

Jonathan Rothberg, PhD, founder and chairman of Hyperfine Research says transformative technologies such as the Swoop™ are born out of out-of-the-box thinking, saying, “Six years ago, we had a crazy vision to create a new product category for imaging: an affordable point-of-care MRI system.”

“With this clearance from the FDA, we are launching an astonishing new diagnostic tool for patients and providers in our Swoop™ Portable MRI, and we are delivering on our mission to democratize healthcare across clinical settings and geographies,” Rothberg adds.

 

Source: Hyperfine, Medgadget.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 15, 2020
Cell & Molecular Biology
Autism Spectrum Disorder Biomarker is Discovered
SEP 15, 2020
Autism Spectrum Disorder Biomarker is Discovered
Scientists may have identified a biomarker for autism spectrum disorder, which can be difficult to differentiate from ot ...
NOV 05, 2020
Clinical & Molecular DX
Digging DEEP into Metabolomic Space
NOV 05, 2020
Digging DEEP into Metabolomic Space
Metabolomics is an umbrella term encompassing lipidomics and the study of smaller polar metabolites.  As such, more ...
NOV 11, 2020
Clinical & Molecular DX
Smart Mask Detects COVID Infections, Sends Alert to Phone
NOV 11, 2020
Smart Mask Detects COVID Infections, Sends Alert to Phone
  This week, the Centers for Disease Control and Prevention issued new guidance to put the “mask debate&rdquo ...
NOV 26, 2020
Clinical & Molecular DX
Routine Diagnostic Tests Linked to a 59 Percent Increase in Testicular Cancer Risk
NOV 26, 2020
Routine Diagnostic Tests Linked to a 59 Percent Increase in Testicular Cancer Risk
New research has revealed that exposure to radiation from diagnostic procedures such as X-rays could contribute to an el ...
DEC 23, 2020
Cancer
A Combination of Photo and Sonodynamic Therapies Could Assist in Treating Brain Cancer
DEC 23, 2020
A Combination of Photo and Sonodynamic Therapies Could Assist in Treating Brain Cancer
Brain cancer is an incredible challenge for modern medicine. Most drugs don’t make it past the blood-brain barrier ...
DEC 29, 2020
Clinical & Molecular DX
Injectable Heart Health Tracker Now Picks Up COVID Red Flags
DEC 29, 2020
Injectable Heart Health Tracker Now Picks Up COVID Red Flags
The statistics are a real eye-opener: in the United States, one person dies every 36 seconds from cardiovascular disease ...
Loading Comments...